(A) Gene expression of Nos-2 in WT and Chrm3−/− BMDM treated with vehicle (black bars) or bethanechol 100 nM (white bars). Data are representative of three experiments.
(B) Gene expression of Arg-1 in WT BMDM treated with vehicle (black bar) or bethanechol (100 nM, white bar). Data are representative of three experiments.
(C) Gene expression of Nos-2 in WT and Chrm3−/− BMDM treated with vehicle (black bars) or atropine 50 nM (white bars). Data are representative of three experiments.
(D) Gene expression of Nos-2 in WT and Chrm3−/− BMDM treated with vehicle or IFN-γ (10 ng/mL, white bars). Data are representative of three experiments.
Student’s t-test was used to determine differences in Nos-2/Arg-1 expression between WT and Chrm3−/− macrophages (A, B, C).
WT: Wild type. Chrm3−/−: M3R-deficient. * p < 0.05 vs. WT vehicle. ** p < 0.01 vs. WT vehicle.
(E) Gene expression of Nos-2 in WT BMDM treated with IFN-γ 10 ng/mL (black bars), IFN-γ 10 ng/mL and bethanechol 100 nM (white bars), and IFN-γ 10 ng/mL, bethanechol 10 nM, and atropine 50 nM (hatched bars). Data are representative of three experiments.
(F) Gene expression of Nos-2 in Chrm3−/− BMDM treated with IFN-γ 10 ng/mL (black bars), IFN-γ 10 ng/mL and bethanechol 100 nM (white bars), and IFN-γ 10 ng/mL, bethanechol 10 nM, and atropine 50 nM (hatched bars). Data are representative of three experiments.
A one-way ANOVA with post hoc analysis for multiple comparisons was used to determine differences between comparisons as indicated below (E, F).
WT: Wild type. Chrm3−/−: M3R-deficient. IFN: interferon-γ. BTH: bethanechol. ATR: atropine.
* p < 0.05 vs. IFN-γ.